Clinical Trials Directory

Trials / Completed

CompletedNCT03209635

Weissella Cibaria JW15 Consumption and NK Cell Activity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

A The aim of this study was to investigate the impact of consuming Weissella cibaria (W. cibaria) JW15 supplementation isolated from Kimchi, Korea traditional fermented food, on natural killer (NK) cell activity and circulating levels of cytokines and immunoglobulin (Ig).

Detailed description

A randomized, double-blinded, placebo-controlled study was conducted on 100 nondiabetic subjects. Over an eight-week testing period, the probiotic group consumed 4 capsules (300 mg/capsule) containing 1 x 10\^10 colony-forming units (cfu) of W. cibaria JW15 each day, whereas the placebo group consumed the same product without a probiotic.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo4 capsules (300 mg/capsule) containing 52% crystalline cellulose and 46% lactose in identical-looking with test product
DIETARY_SUPPLEMENTProbiotic4 capsules (300 mg/capsule) containing each capsule 1.0 x 10\^10 colony-forming units (cfu) of Weissella cibaria JW15, twice a day

Timeline

Start date
2016-04-01
Primary completion
2017-03-20
Completion
2017-03-20
First posted
2017-07-06
Last updated
2017-07-06

Source: ClinicalTrials.gov record NCT03209635. Inclusion in this directory is not an endorsement.